MyAverix Finance
F · Healthcare
BIOGAIA AB B O.N. (BGLA)
Drug Manufacturers - Specialty & Generic
BIOGAIA AB B O.N. (BGLA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $1.04B, P/E ratio is 34.23, net margin is 21.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BGLA
BIOGAIA AB B O.N. (BGLA) — FAQ
What is BIOGAIA AB B O.N.'s market cap?
BIOGAIA AB B O.N. (BGLA) has a reported market cap of $1.04B (data as of 2026-03-28).
What is BGLA's P/E ratio?
The price-to-earnings (P/E) ratio for BIOGAIA AB B O.N. (BGLA) is 34.23 (data as of 2026-03-28).
Does BIOGAIA AB B O.N. pay a dividend?
Dividend yield is not available in the current snapshot for BIOGAIA AB B O.N. (BGLA). Check the MyAverix Finance app for the latest dividend data.
What sector is BIOGAIA AB B O.N. in?
BIOGAIA AB B O.N. (BGLA) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is BGLA listed on?
BGLA is listed on F.
What is BIOGAIA AB B O.N.'s net margin?
BIOGAIA AB B O.N. (BGLA) reports a net margin of 21.6% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.